Cargando…

105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy

BACKGROUND: Recently, we demonstrated in an experimental mouse study that mucosal M-cell targeting with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolide) (PLGA) microspheres represents a promising oral treatment approach in IgE mediated allergy. Due to its structural similarities w...

Descripción completa

Detalles Bibliográficos
Autores principales: Diesner, Susanne C., Schultz, Cornelia, Wang, Xueyan, Ratzinger, Gerda, Starkl, Philipp, Assmann, Vera, Kreiner, Kristina, Roth-Walter, Franziska, Pali-Schöll, Isabella, Jensen-Jarolim, Erika, Gabor, Franz, Untersmayr, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512756/
http://dx.doi.org/10.1097/01.WOX.0000411850.99675.15
_version_ 1782251794585354240
author Diesner, Susanne C.
Schultz, Cornelia
Wang, Xueyan
Ratzinger, Gerda
Starkl, Philipp
Assmann, Vera
Kreiner, Kristina
Roth-Walter, Franziska
Pali-Schöll, Isabella
Jensen-Jarolim, Erika
Gabor, Franz
Untersmayr, Eva
author_facet Diesner, Susanne C.
Schultz, Cornelia
Wang, Xueyan
Ratzinger, Gerda
Starkl, Philipp
Assmann, Vera
Kreiner, Kristina
Roth-Walter, Franziska
Pali-Schöll, Isabella
Jensen-Jarolim, Erika
Gabor, Franz
Untersmayr, Eva
author_sort Diesner, Susanne C.
collection PubMed
description BACKGROUND: Recently, we demonstrated in an experimental mouse study that mucosal M-cell targeting with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolide) (PLGA) microspheres represents a promising oral treatment approach in IgE mediated allergy. Due to its structural similarities with AAL we aimed to assess Neuraminidase (NA) from Vibrio cholerae as a novel M-cell specific targeters and compared its properties to AAL and wheat germ agglutinin (WGA) representing 2 plant lectins, which target either M-cells or epithelial cells, respectively. METHODS: The resistance against gastric digestion of NA, AAL and WGA was analyzed in simulated gastric fluid (SGF) experiments. Intestinal epithelial binding was determined using the colon carcinoma cell line Caco2, which represents a well established model for the human intestinal epithelium. Binding specificity was evaluated by inhibition experiments by incubating Caco2 cells with Biotin-labeled NA, AAL or WGA, after preincubation with a-L fucose, monoganglioside (GM1) or N,N′,N″-triacetyl-chitotriose (TCT). The stimulatory effects of the targeting substances on the intestinal microenvironment were investigated by cytokine read-out experiments in real-time PCR. Further, the transeptihelial uptake of NA-, AAL- or WGA-functionalized fluospheres was evaluated in a human M-cell co-culture model. RESULTS: All 3 targeters were stable up to 180 minutes in SGF, indicating their suitability for oral application. The binding partners were a-L fucose for AAL and TCT for WGA, whereas NA interacts with intestinal epithelial cells via a-L fucose and additionally GM1. NA skewed the cytokine production by inducing a 2-fold increase of the Th1 cytokine IFNg after 60 minutes, whereas AAL decreased the overall cytokine expression. In a human M-cell co-culture model, a higher transepithelial transport rate of fluospheres coated with NA and AAL was observed as compared to WGA and plain particles. CONCLUSIONS: NA specifically targets M-cells via a-L fucose and additionally GM1 and, thus, increases the transepithelial transport of NA coated particles. Due to the immunomodulatory capacity on intestinal epithelial cells, NA functionalized microspheres may represent a promising M-cell specific targeting approach for oral immunotherapy.
format Online
Article
Text
id pubmed-3512756
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35127562012-12-21 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy Diesner, Susanne C. Schultz, Cornelia Wang, Xueyan Ratzinger, Gerda Starkl, Philipp Assmann, Vera Kreiner, Kristina Roth-Walter, Franziska Pali-Schöll, Isabella Jensen-Jarolim, Erika Gabor, Franz Untersmayr, Eva World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Recently, we demonstrated in an experimental mouse study that mucosal M-cell targeting with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolide) (PLGA) microspheres represents a promising oral treatment approach in IgE mediated allergy. Due to its structural similarities with AAL we aimed to assess Neuraminidase (NA) from Vibrio cholerae as a novel M-cell specific targeters and compared its properties to AAL and wheat germ agglutinin (WGA) representing 2 plant lectins, which target either M-cells or epithelial cells, respectively. METHODS: The resistance against gastric digestion of NA, AAL and WGA was analyzed in simulated gastric fluid (SGF) experiments. Intestinal epithelial binding was determined using the colon carcinoma cell line Caco2, which represents a well established model for the human intestinal epithelium. Binding specificity was evaluated by inhibition experiments by incubating Caco2 cells with Biotin-labeled NA, AAL or WGA, after preincubation with a-L fucose, monoganglioside (GM1) or N,N′,N″-triacetyl-chitotriose (TCT). The stimulatory effects of the targeting substances on the intestinal microenvironment were investigated by cytokine read-out experiments in real-time PCR. Further, the transeptihelial uptake of NA-, AAL- or WGA-functionalized fluospheres was evaluated in a human M-cell co-culture model. RESULTS: All 3 targeters were stable up to 180 minutes in SGF, indicating their suitability for oral application. The binding partners were a-L fucose for AAL and TCT for WGA, whereas NA interacts with intestinal epithelial cells via a-L fucose and additionally GM1. NA skewed the cytokine production by inducing a 2-fold increase of the Th1 cytokine IFNg after 60 minutes, whereas AAL decreased the overall cytokine expression. In a human M-cell co-culture model, a higher transepithelial transport rate of fluospheres coated with NA and AAL was observed as compared to WGA and plain particles. CONCLUSIONS: NA specifically targets M-cells via a-L fucose and additionally GM1 and, thus, increases the transepithelial transport of NA coated particles. Due to the immunomodulatory capacity on intestinal epithelial cells, NA functionalized microspheres may represent a promising M-cell specific targeting approach for oral immunotherapy. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512756/ http://dx.doi.org/10.1097/01.WOX.0000411850.99675.15 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Diesner, Susanne C.
Schultz, Cornelia
Wang, Xueyan
Ratzinger, Gerda
Starkl, Philipp
Assmann, Vera
Kreiner, Kristina
Roth-Walter, Franziska
Pali-Schöll, Isabella
Jensen-Jarolim, Erika
Gabor, Franz
Untersmayr, Eva
105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
title 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
title_full 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
title_fullStr 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
title_full_unstemmed 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
title_short 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
title_sort 105 m-cell targeting by neuraminidase functionalized microparticles for future application in oral immunotherapy
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512756/
http://dx.doi.org/10.1097/01.WOX.0000411850.99675.15
work_keys_str_mv AT diesnersusannec 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT schultzcornelia 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT wangxueyan 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT ratzingergerda 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT starklphilipp 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT assmannvera 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT kreinerkristina 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT rothwalterfranziska 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT palischollisabella 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT jensenjarolimerika 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT gaborfranz 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy
AT untersmayreva 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy